- Home
- IMNN vs WKSP Comparison
IMNN vs WKSP Comparison
Compare IMNN & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- WKSP
- Stock Information
- Founded
- IMNN 1982
- WKSP 2003
- Country
- IMNN United States
- WKSP United States
- Employees
- IMNN N/A
- WKSP N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- WKSP Auto Parts:O.E.M.
- Sector
- IMNN Health Care
- WKSP Consumer Discretionary
- Exchange
- IMNN Nasdaq
- WKSP Nasdaq
- Market Cap
- IMNN 12.1M
- WKSP 14.6M
- IPO Year
- IMNN 1985
- WKSP N/A
- Fundamental
- Price
- IMNN $0.77
- WKSP $3.03
- Analyst Decision
- IMNN Buy
- WKSP Strong Buy
- Analyst Count
- IMNN 2
- WKSP 3
- Target Price
- IMNN $14.00
- WKSP $12.83
- AVG Volume (30 Days)
- IMNN 5.4M
- WKSP 177.5K
- Earning Date
- IMNN 08-13-2025
- WKSP 08-12-2025
- Dividend Yield
- IMNN N/A
- WKSP N/A
- EPS Growth
- IMNN N/A
- WKSP N/A
- EPS
- IMNN N/A
- WKSP N/A
- Revenue
- IMNN N/A
- WKSP $10,211,747.00
- Revenue This Year
- IMNN N/A
- WKSP $159.92
- Revenue Next Year
- IMNN N/A
- WKSP $68.25
- P/E Ratio
- IMNN N/A
- WKSP N/A
- Revenue Growth
- IMNN N/A
- WKSP 407.96
- 52 Week Low
- IMNN $0.37
- WKSP $2.44
- 52 Week High
- IMNN $3.65
- WKSP $12.00
- Technical
- Relative Strength Index (RSI)
- IMNN 40.14
- WKSP 50.10
- Support Level
- IMNN $0.93
- WKSP $2.80
- Resistance Level
- IMNN $1.03
- WKSP $3.14
- Average True Range (ATR)
- IMNN 0.18
- WKSP 0.28
- MACD
- IMNN -0.10
- WKSP -0.01
- Stochastic Oscillator
- IMNN 1.39
- WKSP 30.00
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.